Live Breaking News & Updates on Mink Therapeutics Inc

Stay updated with breaking news from Mink therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MiNK Therapeutics, Inc. (NASDAQ:INKT) Sees Large Growth in Short Interest

MiNK Therapeutics, Inc. (NASDAQ:INKT – Get Free Report) saw a large increase in short interest during the month of May. As of May 15th, there was short interest totalling 516,900 shares, an increase of 490.7% from the April 30th total of 87,500 shares. Approximately 5.2% of the shares of the stock are short sold. Based […] ....

Mink Therapeutics Inc , Get Free Report ,

MiNK Therapeutics, Inc. (NASDAQ:INKT) Short Interest Up 490.7% in May

MiNK Therapeutics, Inc. (NASDAQ:INKT – Get Free Report) was the recipient of a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 516,900 shares, an increase of 490.7% from the April 30th total of 87,500 shares. Based on an average daily volume of 183,900 shares, […] ....

Mink Therapeutics Inc , Get Free Report ,

Analyzing MiNK Therapeutics (NASDAQ:INKT) and SpringWorks Therapeutics (NASDAQ:SWTX)

MiNK Therapeutics (NASDAQ:INKT – Get Free Report) and SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, profitability and valuation. Valuation & Earnings This table compares MiNK Therapeutics […] ....

United States , New York , Katholieke Universiteit Leuven , Agenus Inc , Mink Therapeutics Inc , Flanders Institute For Biotechnology , Dana Farber Cancer Institute , Springworks Therapeutics Inc , Beigene Ltd , Agentus Therapeutics Inc , Pfizer Inc , Get Free Report , Springworks Therapeutics , Springworks Therapeutic , Agentus Therapeutics , Works Therapeutics , Flanders Institute , Epidermal Growth Factor ,

MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting

NEW YORK, May 22, 2024 MiNK Therapeutics, Inc. , a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant. ....

United States , New York , Terese Hammond , Mink Therapeutics Inc , American Thoracic Society , University Of California Los Angeles , California Los , Nat Commun , Risk Factors ,

Head to Head Analysis: SpringWorks Therapeutics (NASDAQ:SWTX) & MiNK Therapeutics (NASDAQ:INKT)

SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report) and MiNK Therapeutics (NASDAQ:INKT – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, profitability, analyst recommendations, dividends, risk, valuation and institutional ownership. Valuation and Earnings This table compares SpringWorks Therapeutics […] ....

United States , New York , Katholieke Universiteit Leuven , Springworks Therapeutics Inc , Agenus Inc , Dana Farber Cancer Institute , Mink Therapeutics Inc , Agentus Therapeutics Inc , Flanders Institute For Biotechnology , Pfizer Inc , Beigene Ltd , Springworks Therapeutics , Get Free Report , Works Therapeutics , Flanders Institute , Epidermal Growth Factor , Agentus Therapeutics , Springworks Therapeutics Daily ,